Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
cephalosporin |
| gptkbp:ATCCode |
gptkb:J01DB01
|
| gptkbp:CASNumber |
61-33-6
|
| gptkbp:category |
first-generation cephalosporin
|
| gptkbp:chemicalFormula |
C16H21N3O8S
|
| gptkbp:discoveredBy |
gptkb:Giuseppe_Brotzu
|
| gptkbp:discoveredIn |
1948
|
| gptkbp:foundIn |
gptkb:Acremonium_chrysogenum
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cephalosporin C
|
| gptkbp:IUPACName |
(6R,7R)-7-[(2R)-2-amino-2-carboxyethylamino]-3-(acetoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
| gptkbp:mechanismOfAction |
inhibits bacterial cell wall synthesis
|
| gptkbp:molecularWeight |
415.42 g/mol
|
| gptkbp:predecessor |
semisynthetic cephalosporins
|
| gptkbp:PubChem_CID |
6437465
|
| gptkbp:routeOfAdministration |
intramuscular
intravenous |
| gptkbp:sideEffect |
allergic reaction
gastrointestinal disturbance |
| gptkbp:usedFor |
gptkb:Bacteria
|
| gptkbp:bfsParent |
gptkb:Cephalosporium_acremonium
|
| gptkbp:bfsLayer |
7
|